Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
TBCRC 049 UAB 1794: A Phase II Non-randomized Study to Assess the Safety and Efficacy of the Combination of Tucatinib and Trastuzumab and Capecitabine for Treatment of Leptomeningeal Metastases in HER2 Positive Breast Cancer
Grant
Overview
Affiliation
Overview
Awarded By
Johns Hopkins University
Total Award Amount
53238.00
Direct Costs
40952.00
Sponsor Award Id
Affiliation
Contributor
Erica Stringer-Reasor M.D.
Principal Investigator
Gabrielle Rocque M.D.
Investigator
Louis Nabors M.D.
Investigator